Cytokinin activity in rose petals and its relation to senescence
1The Volcani Institute of Agricultural Research, and Department of Floriculture, The Hebrew University, Rehovot, Israel.
Plant Physiology
|October 1, 1970
Abstract:
Cytokinin activity in young rose petals was higher than in old ones. The content of endogenous cytokinins in petals of a short-lived variety (Golden Wave) was lower than in a long-lived variety (Lovita). Application of the cytokinin, N(6)-benzyladenine, increased longevity of the short-lived variety. This strengthens the view that cytokinins participate in the endogenous regulation of senescence in rose petals.
Related Concept Videos
Cell Signaling in Plants
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

